Literature DB >> 33517526

Developmental Skills of Individuals with Angelman Syndrome Assessed Using the Bayley-III.

Anjali Sadhwani1,2, Anne Wheeler3, Lynne M Bird4,5, Wen-Hann Tan6,7, Angela Gwaltney3, Sarika U Peters8, Rene L Barbieri-Welge9, Lucia T Horowitz10, Lisa M Noll11,12, Rachel J Hundley8.   

Abstract

We describe the development of 236 children with Angelman syndrome (AS) using the Bayley Scales of Infant and Toddler Development, Third Edition. Multilevel linear mixed modeling approaches were used to explore differences between molecular subtypes and over time. Individuals with AS continue to make slow gains in development through at least age 12 years of age at about 1-2 months/year based on age equivalent score and 1-16 growth score points/year depending on molecular subtype and domain. Children with a deletion have lower scores at baseline and slower rate of gaining skills while children with UBE3A variant subtype demonstrated higher scores as well as greater rates of skill attainment in all domains. The developmental profiles of UPD and ImpD were similar.

Entities:  

Keywords:  Child development; Developmental disabilities; Language development disorders; Motor skills disorders; Neurodevelopmental disorders

Year:  2021        PMID: 33517526      PMCID: PMC8322148          DOI: 10.1007/s10803-020-04861-1

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  37 in total

1.  A neurodevelopmental survey of Angelman syndrome with genotype-phenotype correlations.

Authors:  Jennifer K Gentile; Wen-Hann Tan; Lucia T Horowitz; Carlos A Bacino; Steven A Skinner; Rene Barbieri-Welge; Astrid Bauer-Carlin; Arthur L Beaudet; Terry Jo Bichell; Hye-Seung Lee; Trilochan Sahoo; Susan E Waisbren; Lynne M Bird; Sarika U Peters
Journal:  J Dev Behav Pediatr       Date:  2010-09       Impact factor: 2.225

2.  Behavioral phenotypes of genetic syndromes with intellectual disability: comparison of adaptive profiles.

Authors:  Santo Di Nuovo; Serafino Buono
Journal:  Psychiatry Res       Date:  2011-04-19       Impact factor: 3.222

3.  Predictive validity in middle childhood of short tests of early childhood development used in large scale studies compared to the Bayley-III, the Family Care Indicators, height-for-age, and stunting: A longitudinal study in Bogota, Colombia.

Authors:  Marta Rubio-Codina; Sally Grantham-McGregor
Journal:  PLoS One       Date:  2020-04-29       Impact factor: 3.240

4.  Autism in Angelman syndrome: implications for autism research.

Authors:  S U Peters; A L Beaudet; N Madduri; C A Bacino
Journal:  Clin Genet       Date:  2004-12       Impact factor: 4.438

5.  Molecular and Clinical Aspects of Angelman Syndrome.

Authors:  A Dagli; K Buiting; C A Williams
Journal:  Mol Syndromol       Date:  2011-07-28

Review 6.  Angelman syndrome: a review of the clinical and genetic aspects.

Authors:  J Clayton-Smith; L Laan
Journal:  J Med Genet       Date:  2003-02       Impact factor: 6.318

7.  Exploring Expressive Communication Skills in a Cross-Sectional Sample of Children and Young Adults With Angelman Syndrome.

Authors:  Emily D Quinn; Charity Rowland
Journal:  Am J Speech Lang Pathol       Date:  2017-05-17       Impact factor: 2.408

8.  Neurodevelopmental profile in Angelman syndrome: more than low intelligence quotient.

Authors:  S Micheletti; F Palestra; P Martelli; P Accorsi; J Galli; L Giordano; V Trebeschi; E Fazzi
Journal:  Ital J Pediatr       Date:  2016-10-21       Impact factor: 2.638

9.  An overview of health issues and development in a large clinical cohort of children with Angelman syndrome.

Authors:  Karen G C B Bindels-de Heus; Sabine E Mous; Maartje Ten Hooven-Radstaake; Bianca M van Iperen-Kolk; Cindy Navis; André B Rietman; Leontine W Ten Hoopen; Alice S Brooks; Ype Elgersma; Henriëtte A Moll; Marie-Claire Y de Wit
Journal:  Am J Med Genet A       Date:  2019-11-15       Impact factor: 2.802

View more
  6 in total

1.  Case Report: Autism Risk Within the Context of Two Chromosome 15 Syndromes.

Authors:  Ashleigh M Kellerman; Mehreen Z Hassan; Emily A Abel; Molly Reilly; Rebecca McNally Keehn; A J Schwichtenberg
Journal:  J Autism Dev Disord       Date:  2022-01-07

Review 2.  Natural History Studies and Clinical Trial Readiness for Genetic Developmental and Epileptic Encephalopathies.

Authors:  Elizabeth E Palmer; Katherine Howell; Ingrid E Scheffer
Journal:  Neurotherapeutics       Date:  2021-10-27       Impact factor: 6.088

3.  Epilepsy and Molecular Phenotype Affect the Neurodevelopment of Pediatric Angelman Syndrome Patients in China.

Authors:  Shuang Li; Yu Ma; Tianqi Wang; Huimin Jin; Xiaonan Du; Yi Wang
Journal:  Front Psychiatry       Date:  2022-04-28       Impact factor: 5.435

4.  An Analysis of Phenotype and Genotype in a Large Cohort of Chinese Children with Angelman Syndrome.

Authors:  Xiaonan Du; Ji Wang; Shuang Li; Yu Ma; Tianqi Wang; Bingbing Wu; Yuanfeng Zhou; Lifei Yu; Yi Wang
Journal:  Genes (Basel)       Date:  2022-08-14       Impact factor: 4.141

5.  Gait as a quantitative translational outcome measure in Angelman syndrome.

Authors:  Stela P Petkova; Anna Adhikari; Elizabeth L Berg; Timothy A Fenton; Jessica Duis; Jill L Silverman
Journal:  Autism Res       Date:  2022-03-10       Impact factor: 4.633

6.  Delta power robustly predicts cognitive function in Angelman syndrome.

Authors:  Lauren M Ostrowski; Elizabeth R Spencer; Lynne M Bird; Ronald Thibert; Robert W Komorowski; Mark A Kramer; Catherine J Chu
Journal:  Ann Clin Transl Neurol       Date:  2021-05-28       Impact factor: 4.511

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.